Who is sponsoring NCT06198985?

NCT06198985 is sponsored by Hakan Alkan.

What drugs are being tested in NCT06198985?

Interventions in NCT06198985: Dynamic balance exercise with tecnobody prokin 252 balance device.

What condition does NCT06198985 study?

NCT06198985 studies Ankylosing Spondylitis.

Is NCT06198985 still recruiting?

NCT06198985 is currently status unknown. Last updated 10 January 2024.

Last reviewed 2024-01-10 · How we verify

NCT06198985

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Dynamic Balance Exercises on Balance in Patients With Ankylosing Spondylitis.

Status unknown NA Last updated 10 January 2024

What this trial tests

NA trial testing Dynamic balance exercise with tecnobody prokin 252 balance device in Ankylosing Spondylitis in 40 participants. Status unknown.

Timeline

1 January 2024

Primary endpoint
1 July 2025

1 July 2025

Quick facts

Lead sponsor	Hakan Alkan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	1 January 2024
Primary completion	1 July 2025
Estimated completion	1 July 2025

Drugs / interventions tested

Dynamic balance exercise with tecnobody prokin 252 balance device

Conditions studied

Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →

Sponsor

Hakan Alkan

Who can join

Adults 18 to 65, any sex, with Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the effect of dynamic balance exercises added to current medical treatment on balance in patients with ankylosing spondylitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ankylosing Spondylitis

Currently open trials in the same condition.

NCT07510789 — Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis · recruiting
NCT07261644 — A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) · Phase 3 · recruiting
NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
NCT06905288 — Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. · recruiting
NCT07166874 — The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06198985 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hakan Alkan
Last refreshed: 10 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06198985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing